Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by independent educational grants from AbbVie; Celgene Corporation; Lilly USA, LLC; Merck & Co., Inc.; and Pfizer, Inc.
Target Audience: The intended audience for this activity is rheumatologists and other health care professionals involved in the treatment of patients with rheumatic disease.
Learning Objectives: Upon successful completion of this activity, participants should be better able to:
- Assess patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or spondyloarthritis (SpA) for disease activity, prognosis, and comorbidities such as serious and opportunistic infections, cardiovascular disease, mental health disorders, and other complications.
- Apply the latest treat-to-target guideline approaches for the management of patients with RA, PsA, or SpA.
- Identify and incorporate best practices for the prevention and monitoring of complications for patients with RA, PsA, or SpA, including risk profiling and vaccinations.
Activity Co-Chairs:
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, OH
M. Elaine Husni, MD, MPH
Vice Chair of Rheumatology
Director, Arthritis and Musculoskeletal Center
Cleveland Clinic
Assistant Professor
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, OH
Faculty:
Cassandra Calabrese, DO
Rheumatology and Infectious Disease
Cleveland Clinic Foundation
Cleveland, OH
Jeffrey L. Kaine, MD
Director, Sarasota Arthritis Research Center
Sarasota, FL
Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Medical Writer:
Valerie Zimmerman, PhD
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, November 15, 2018 to November 15, 2019.
How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, review the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors
disclose that they do have significant financial interests in any products or
class of products discussed directly or indirectly in this activity, including
research support.
Activity Co-Chairs and Faculty report the following relationship(s):
Cassandra Calabrese, DO
No relevant financial relationships to disclose.
Leonard H. Calabrese, DO
Consulting Fee: Amgen, GlaxoSmithKline, Horizon, Janssen, Pfizer, Regeneron, Sanofi, UCB
Speakers Bureau: AbbVie, Bristol-Myers Squibb, Crescendo, Genentech, Janssen, UCB
M. Elaine Husni, MD, MPH
Consulting Fee: AbbVie, Janssen, Lilly, Novartis, Pfizer, Prime Education, UCB, WebMD
Contracted Research: Pfizer
Jeffrey L. Kaine, MD
No relevant financial relationships to disclose.
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Medical Writer reports the following relationship(s):
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com